Mvitro (CEO Youngwoo Lee), a home care medical device R&D company based on laser technology, announced at CES 2025, the world's largest IT exhibition, that it has finalized a contract to supply blood glucose measuring device 'ORTIV' with ASI (Applied Science Inc.) of the United States. Through this contract, Mvitro will supply 10,000 units of ORTIV to ASI this year and 20,000 units next year.
ASI is a company that supplies medical equipment to blood transfusion organizations and medical institutions in the United States. ASI plans to test Otive in a cohort group of less than 10,000 people in cooperation with a Federally Qualified Health Center (FQHC) in the United States and then begin full-scale distribution. This contract was finalized after final negotiations at CES 2025.
ASI commissioned Embitro to develop a hemoglobin measuring device that uses Otive’s painless laser blood sampling technology. Embitro has developed the hemoglobin measuring device Otive-H and is preparing for FDA certification.
Mvitro, which has participated in CES for three consecutive years since 2023, received much attention this time by being selected as a 'Featured Exhibitor' in the 'Digital Health' category. During the exhibition, visitors flocked to the Mvitro booth to experience Otive's painless laser blood collection and blood sugar measurement functions for themselves, and long lines formed until the last day.
Since receiving FDA approval for Otive’s laser part in December last year, full-scale contract discussions with global companies have begun at this year’s CES. Currently, Mvitro is also in discussions with 24 buyers from 9 countries including Canada, Saudi Arabia, India, China, and Mexico.
CVS, the largest pharmacy chain in the U.S., also showed keen interest in Otive and began sales talks, according to Embitro. CVS has a chain of about 9,900 pharmacies across the U.S.
In Korea, clinical trials are underway with the goal of obtaining Korea Food and Drug Safety (KFDA) certification for Otive in the first half of this year, and domestic sales are planned to begin as soon as approval is granted.
- See more related articles
You must be logged in to post a comment.